FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Lupin Pharmaceuticals,Inc.

Lupin Pharmaceuticals has received FDA approval for the generic version of Hydrocodone Bitartrate and Acetaminophen, targeting a product market currently dominated by generics. The addition of this solid-dosage drug to Lupin’s portfolio is poised to bolster its portfolio of oral opioids and further intensify competitive pricing pressure within the branded drug sector.